Irinotecan trials for Lung cancer

All Irinotecan trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Irinotecan for Lung cancer

• A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
  NCT06954246 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
  NCT05800587 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
  NCT06496048 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
  NCT06586515 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations
• Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
  NCT07155200 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Irinotecan for Lung cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.